The National Medical Products Administration (NMPA) has released the 77th batch of reference drugs for generic quality consistency evaluation (GQCE) work, marking another step in ensuring the quality and consistency of generic medications in the country. This batch includes 62 new specifications and 30 modified specifications for generic drugs, with 9 and 6 of these being injectable formulations, respectively.
The release of these reference drugs is part of the ongoing efforts to standardize the generic drug market, ensuring that these medications meet the same strict quality standards as their brand-name counterparts. The specifications detailed in the NMPA’s release provide a benchmark for manufacturers to follow when producing generic versions of these drugs.- Flcube.com
